Mazen Noureddin
Physician · Houston Methodist Hospital
Credentials: · · · ·
History
- 2026–Present
2016–2018
2010–2011
- 1998–2002
Doctor of Medicine
Research
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
New England Journal of Medicine · 2024 · 1,637 citations
The global burden of metabolic disease: Data from 2000 to 2019
Cell Metabolism · 2023 · 651 citations
Systematic review or meta-analysis · The Lancet. Gastroenterology & hepatology · 2023 · 618 citations
68 papers
60 papers
51 papers · 4 as a fellow
50 papers
42 papers · 26 as a fellow
- PD
Pojsakorn Danpanichkul
40 papers
- SH
35 papers
26 papers
Grants
- 2026–2031
Non-Invasive Detection of Liver Fibrosis Utilizing the MASML Machine Learning Algorithm
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $439.6K · Methodist Hospital Research Institute
Clinical trials
- 2025–2029
Assessment of Non-Invasive Testing in Major Liver-Related Outcomes
Principal investigator · Enrolling by invitation
HRI-MAIL-NIT
- 2014–2015
The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease Patients
Principal investigator · Withdrawn
University of Southern California